Stimulation of tumor cell growthin vitro by a monoclonal antibody to a tumor specific protein (TSP-180) present on the cell surface of 3LL cells
- 1 January 1989
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 7 (1) , 41-54
- https://doi.org/10.1007/bf02057180
Abstract
Proliferation capacity and MHC class I antigen expression of two Lewis lung carcinoma (3LL) metastatic variants (C87, BC215) grown under defined experimental conditions (serum-free defined medium or 10 per cent serum) have been studied following exposure to Mo Ab 135-13C which recognizes on these cells a tumor surface protein of 180000 daltons (TSP-180). The results of this study indicate that the high metastatic clone (C87) binds higher amounts of MoAb to TSP-180 and Db antigens than does the low metastatic one (BC215), while both clones express very low amounts of Kb antigens. 3LL clones grown in 10 per cent serum or adapted in serum-free, defined medium show the same metastatic phenotype and MHC class I antigen expression, but when grown in defined medium exhibit increased capacity to bind MoAb 135-13C. However, the relative binding rate of 3LL clones grown in 10 per cent serum or in defined medium is unchanged: the high metastatic clone always showing higher capacity to bind MoAb to TSP-180. Furthermore, comparison of EGF binding sites on the cell surface of 3LL clones, grown in different culture conditions, demonstrates that the C87 clone binds higher amounts of labelled EGF and that this amount increases in serum-free defined medium, exactly as reported for TSP-180. In addition, competition experiments demonstrated that MoAb 135-13C does not compete for EGF binding sites on 3LL cell surface. Studies on cell proliferation following exposure to MoAb 135-13C, revealed that the low metastatic clone (BC215) is more actively stimulated than the high metastatic one. Moreover, similar data were obtained after exposure of 3LL clones to physiological amounts of different growth factors (i.e. EGF, MSA, insulin). Analysis of MHC class I antigen expression following exposure to MoAb 13S-13C indicated that MoAb 135-13C induces on the cell surface of the C87 clone a transient low modulation of Db antigens. These results suggest that 3LL cells endowed with lower metastatic potential are more dependent on the microenvironmental conditions than the high metastasizing ones, and that MoAb 135-13C binding to 3LL cell surface stimulates proliferation as reported for several known growth factors.Keywords
This publication has 26 references indexed in Scilit:
- Metastatic dissemination of 3LL variants after treatment with monoclonal antibody to a tumor-associated antigenClinical & Experimental Metastasis, 1987
- Purification and characterization of the receptor for insulin-like growth factor IBiochemistry, 1986
- The major histocompatibility complex class I heavy chain as a structural subunit of the human cell membrane insulin receptor: implications for the range of biological functions of histocompatibility antigens.Proceedings of the National Academy of Sciences, 1986
- Heterogeneity in surface antigen of cell lines and clones from a murine carcinomaInternational Journal of Cancer, 1985
- Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine, and characterization of an antigen associated with metastatic activity.Proceedings of the National Academy of Sciences, 1984
- Changes of phenotypic characteristics of variants derived from Lewis lung carcinoma during long-term in vitro growthClinical & Experimental Metastasis, 1984
- Purification of IgG monoclonal antibody by caprylic acid precipitationJournal of Immunological Methods, 1983
- Changes in malignant phenotype of a human carcinoma conditioned by growth environmentCell, 1983
- Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.Proceedings of the National Academy of Sciences, 1983
- Shifts in Tumor Cell Phenotypes Induced by Signals from the MicroenvironmentImmunobiology, 1980